TY - JOUR
T1 - Sensitization to multiple Rh antigens by transfusion of random donor platelet concentrates in a-D-phenotype patient
AU - Yun, Jae Won
AU - Kang, Eun Suk
AU - Ki, Chang Seok
AU - Koh, Kwang Cheol
AU - Kim, Dae Won
PY - 2012/11
Y1 - 2012/11
N2 - The -D- phenotype is a rare Rh phenotype that strongly expresses D antigen without C, c, E, or e antigens. In -D- phenotype individuals, anti-Rh17 (Hro) is commonly found if there is a history of pregnancy or transfusion with red blood cells (RBCs) that express C, c, E, or e antigens. We report the first case of a -D- phenotype patient with multiple Rh antibodies including anti-Rh17 who had a history of two occasions of transfusion with eight random donor platelet concentrates two and six years ago. We found that a trivial amount of RBCs in the platelet components was able to trigger sensitization to RBC antigens, especially the highly immunogenic and clinically significant Rh antigens, including C, c, E, e or CcEe polypeptides. To avoid unnecessary sensitization and to minimize the risk of hemolytic transfusion reactions in patients with this rare Rh phenotype, a modified strategy for pretransfusion screenings needs to be discussed in the field of transfusion medicine.
AB - The -D- phenotype is a rare Rh phenotype that strongly expresses D antigen without C, c, E, or e antigens. In -D- phenotype individuals, anti-Rh17 (Hro) is commonly found if there is a history of pregnancy or transfusion with red blood cells (RBCs) that express C, c, E, or e antigens. We report the first case of a -D- phenotype patient with multiple Rh antibodies including anti-Rh17 who had a history of two occasions of transfusion with eight random donor platelet concentrates two and six years ago. We found that a trivial amount of RBCs in the platelet components was able to trigger sensitization to RBC antigens, especially the highly immunogenic and clinically significant Rh antigens, including C, c, E, e or CcEe polypeptides. To avoid unnecessary sensitization and to minimize the risk of hemolytic transfusion reactions in patients with this rare Rh phenotype, a modified strategy for pretransfusion screenings needs to be discussed in the field of transfusion medicine.
KW - Platelet transfusion
KW - Rh isoimmunization
KW - Rh-Hr blood group system
UR - https://www.scopus.com/pages/publications/84868535346
U2 - 10.3343/alm.2012.32.6.429
DO - 10.3343/alm.2012.32.6.429
M3 - Article
C2 - 23130343
AN - SCOPUS:84868535346
SN - 2234-3806
VL - 32
SP - 429
EP - 432
JO - Annals of Laboratory Medicine
JF - Annals of Laboratory Medicine
IS - 6
ER -